Human papillomavirus type 33 infection
Human papillomavirus type 33 infection has been studied in 1 paper since 2025: 1 observational study in people; 1 in the past year. The newest paper, Dec 16, 2025: “Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study”.
1 paper studies it1 findingUpdated
See all 1 papers on human papillomavirus type 33 infection
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Infection with HPV33 (OR = 2.40, 95% CI: 1.42-4.01)”
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- Humans1
What is human papillomavirus type 33 infection linked with?
1Studies link human papillomavirus type 33 infection with 3-year HR-HPV persistence.
3-year HR-HPV persistence
upin humans1OR 2.4
1 study
3-year HR-HPV persistence
upin humans1OR 2.4
Human papillomavirus type 33 infection is associated with 3-year HR-HPV persistence in humans (HR-HPV positive at baseline) (OR 2.40, 95% CI 1.42–4.01).
“Infection with HPV33 (OR = 2.40, 95% CI: 1.42-4.01)”
HumansHR-HPV positive at baseline3 yearsfemalesn = 1,684
Virology journal